Nebula Research & Development LLC Bridge Bio Pharma, Inc. Transaction History

Nebula Research & Development LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	SELL	$28.12 - $37.59 $580,959 - $776,609	-20,660 Reduced 57.01%	15,579 $539 Million
Q4 2024 Feb 14, 2025	BUY	$22.35 - $29.5 $388,890 - $513,300	17,400 Added 92.36%	36,239 $994 Million
Q3 2024 Nov 14, 2024	BUY	$23.91 - $31.3 $450,440 - $589,660	18,839 New	18,839 $480 Million

445

184M

11.3M

1.84M

Ticker BBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 148,246,000
Market Cap $9.84B
Description
BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...

Get notified when there are updates to the investment portfolio of Nebula Research & Development LLC, based on Form 13F filings with the SEC.

Stay updated on Nebula Research & Development LLC with notifications on news.